EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-1.78%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$7.79B
AUM Growth
-$363M
(-4.5%)
Cap. Flow
+$111M
Cap. Flow
% of AUM
1.43%
Top 10 Holdings %
Top 10 Hldgs %
26.25%
Holding
934
New
33
Increased
159
Reduced
182
Closed
39
Top Buys
| 1 |
TJX Companies
TJX
|
$71.6M |
| 2 |
iShares Gold Trust
IAU
|
$68.6M |
| 3 |
Philip Morris
PM
|
$60.4M |
| 4 |
Booking.com
BKNG
|
$54.8M |
| 5 |
Flowserve
FLS
|
$44.5M |
Top Sells
| 1 |
Costco
COST
|
$69.8M |
| 2 |
AutoZone
AZO
|
$42.7M |
| 3 |
Starbucks
SBUX
|
$42.5M |
| 4 |
Texas Roadhouse
TXRH
|
$36.1M |
| 5 |
Morgan Stanley
MS
|
$21.1M |
Sector Composition
| 1 | Technology | 32.54% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 13.77% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
Fabrinet
FN
$13.2B
| $5.03M | 0.06% |
25,361
-3,424
| -12% | -$679K |
|
227
BridgeBio Pharma
BBIO
$10.2B
| $4.92M | 0.06% |
140,225
| – | – |
|
228
HP
HPQ
$27.4B
| $4.66M | 0.06% |
+167,100
| New | +$4.66M |
|
229
Wheaton Precious Metals
WPM
$47.3B
| $4.61M | 0.06% |
+60,500
| New | +$4.61M |
|
230
Amphenol
APH
$135B
| $4.48M | 0.06% |
65,581
+8,501
| +15% | +$581K |
|
231
Hilton Worldwide
HLT
$64B
| $4.42M | 0.06% |
19,600
| – | – |
|
232
Rockwell Automation
ROK
$38.2B
| $4.42M | 0.06% |
17,099
-2,948
| -15% | -$762K |
|
233
Fluence Energy
FLNC
$989M
| $4.4M | 0.06% |
885,035
-226,594
| -20% | -$1.13M |
|
234
Motorola Solutions
MSI
$79.8B
| $4.36M | 0.06% |
10,071
-441
| -4% | -$191K |
|
235
ZTO Express
ZTO
$14.7B
| $4.33M | 0.06% |
214,876
| – | – |
|
236
Exxon Mobil
XOM
$466B
| $4.31M | 0.06% |
36,650
+14,055
| +62% | +$1.65M |
|
237
Jones Lang LaSalle
JLL
$14.8B
| $4.25M | 0.05% |
17,269
+664
| +4% | +$163K |
|
238
Royal Bank of Canada
RY
$204B
| $4.21M | 0.05% |
36,900
-33,700
| -48% | -$3.85M |
|
239
ResMed
RMD
$40.6B
| $4.19M | 0.05% |
+18,800
| New | +$4.19M |
|
240
Acadia Pharmaceuticals
ACAD
$4.26B
| $4.14M | 0.05% |
242,300
| – | – |
|
241
Lowe's Companies
LOW
$151B
| $4.13M | 0.05% |
18,063
+32
| +0.2% | +$7.31K |
|
242
Xencor
XNCR
$610M
| $4.06M | 0.05% |
380,200
+28,000
| +8% | +$299K |
|
243
Omega Healthcare
OHI
$12.7B
| $4.05M | 0.05% |
106,420
+3,067
| +3% | +$117K |
|
244
Idexx Laboratories
IDXX
$51.4B
| $4.02M | 0.05% |
9,670
+6,380
| +194% | +$2.65M |
|
245
BioNTech
BNTX
$27B
| $3.99M | 0.05% |
+42,000
| New | +$3.99M |
|
246
Broadridge
BR
$29.4B
| $3.96M | 0.05% |
+16,575
| New | +$3.96M |
|
247
Ares Capital
ARCC
$15.8B
| $3.91M | 0.05% |
174,800
-9,200
| -5% | -$206K |
|
248
Trimble
TRMB
$19.2B
| $3.88M | 0.05% |
59,282
-9,124
| -13% | -$598K |
|
249
Voyager Therapeutics
VYGR
$235M
| $3.83M | 0.05% |
1,116,793
+58,415
| +6% | +$200K |
|
250
Danaher
DHR
$143B
| $3.8M | 0.05% |
18,461
-43
| -0.2% | -$8.85K |
|